Dashboard
Analysis
Charting
Screener
Resources
Settings
NasdaqGS-CRWD
Jan '17
Oct '18
Jan '20
Apr '21
Jul '22
Oct '23
Jan '25
Trailing Valuation
Stock Price
543
454.6
428.9
398.1
296.9
232
Total Shares Outstanding
252.1
250.8
249.1
247.9
246.3
245.1
Market Cap
136,880.9
114,018.4
106,820.4
98,670.4
73,121.8
56,858.5
Total Enterprise Value (TEV)
132,940.4
109,894.5
103,031.7
95,175.4
69,691.1
53,649.6
Buyback Yield
-0%
-0.1%
Debt Paydown Yield
—
Shareholder Yield
P/S
30
26.3
25.8
25
19.5
16.2
P/Gross Profit
40.5
35.5
34.7
33.3
26
21.5
P/E
-431
-382
-621.6
-4,975.9
582.1
336.2
Earnings Yield
-0.2%
-0.3%
0.2%
0.3%
P/OCF
93.7
82.1
77.3
71.4
52.9
42.7
P/FCF
116.7
103
97.8
87.6
62.9
48.7
FCF Yield
0.9%
1%
1.1%
1.6%
2.1%
P/B
34.1
30.4
31
30.1
23.9
19.9
EV/Sales
29.1
25.3
24.9
24.1
18.6
15.3
EV/Gross Profit
39.3
34.2
33.4
32.1
24.8
20.2
EV/EBITDA
-1,014.9
-820.9
-4,540.2
1,017.6
360.3
227.8
EV/EBIT
-338.8
-290.2
-408.8
-790.3
-12,768.6
1,004.1
EV/OCF
91
79.1
74.5
68.9
50.4
40.3
EV/FCF
113.3
99.3
94.4
84.5
59.9
45.9
Margins
Gross Profit Margin
74.1%
74%
74.5%
74.9%
75.2%
75.4%
Operating Margin
-8.6%
-8.7%
-6.1%
-3%
1.5%
EBITDA Margin
-2.9%
-3.1%
-0.5%
2.4%
5.2%
6.7%
Net Profit Margin
-6.9%
-4.2%
-0.4%
3.5%
5%
Effective Tax Rate
-36.3%
-36.4%
-94.7%
130.4%
22.7%
19.3%
Pre-Tax Profit Margin
-5.1%
-5%
-2.2%
1.4%
4.5%
6.2%
Free Cash Flow Margin
25.7%
25.5%
26.4%
28.5%
31.1%
33.2%
OCF / Sales
32%
33.4%
34.9%
37%
37.8%
OCF / Net Income
-463%
-465.7%
-795.3%
-8,325.7%
1,055.1%
762.1%
FCF / OCF
80.4%
79.7%
79%
81.6%
84.1%
87.8%
FCF / Net Income
-372.1%
-371.1%
-627.9%
-6,790%
887.1%
668.9%
FCF / EBITDA
-895.7%
-826.6%
-4,810.7%
1,204.9%
601.2%
495.8%
Capital Efficiency
Return on Invested Capital
-9.7%
-10.1%
0.7%
Return on Assets
-6%
-5.9%
0.4%
Return on Equity
-8.8%
-5.3%
5.1%
7.1%
Return on Total Capital
-63.3%
-61.6%
-59.3%
4.4%
Return on Capital Employed
-7%
-7.1%
-4.9%
-2.4%
1.3%
Return on Tangible Assets
-4.1%
-3.9%
2.2%
3%
Receivables Turnover
5
5.1
4.1
5.4
5.8
Days Sales Outstanding
73
71.5
71.6
89.7
67.1
63.5
Payables Turnover
11.2
11.3
22.1
9.4
13.6
22.2
Days Payables Outstanding
32.6
32.3
16.5
38.7
26.8
16.4
Cash Conversion Cycle
39.2
55.1
51
47
Asset Turnover
0.5
Fixed Asset Turnover
4.9
5.3
Operating Cycle
CapEx to OCF
0.2
0.1
CapEx to Revenue
0
CapEx to Depreciation
1.1
1.2
1.3
0.9
Financial Health
Total Debt
818
810.5
785.4
788.9
792
Net Debt
-3,983
-4,161.9
-3,828.8
-3,534.4
-3,468.4
-3,246.6
Current Ratio
1.8
1.9
Quick Ratio
1.6
1.7
Cash Ratio
1.4
1.5
Debt Ratio
Assets to Equity
2.5
2.4
2.6
Cash Flow to Debt Ratio
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
570.4
1,002.2
801.3
691.3
847.3
832.1
Goodwill / Assets
Debt / Equity
0.3
Total Debt / Capitalization
1
Long Term Debt / Capitalization
Long-Term Debt / Equity
Net Debt / EBITDA
31.1
168.7
-37.8
-17.9
-13.8
EBIT / Interest Expense
-14.5
-14.1
-9.5
-4.6
-0.2
2.1
EBITDA / Interest Expense
-4.8
-5
-0.9
3.6
7.4
9.1
(EBITDA - Capex) / Interest Expense
-15.4
-15.5
-11.8
-6.1
-1
2.8
Per Share
Revenue per Share
18.3
17.5
16.7
15
14.2
Basic EPS
-1.3
-1.2
-0.7
-0.1
0.7
Diluted EPS
Book Value per Share
16.1
15.2
13.9
13.4
12.3
11.5
Tangible Book Value per Share
10.1
11
9.7
9
8.1
Cash per Share
19.3
20.1
17.7
17.1
16.3
Operating Cash Flow per Share
5.9
5.6
Free Cash Flow per Share
4.7
4.5
4.4
4.6
CapEx per Share
Weighted Avg. Shares Outstanding
249.2
247.7
246.2
244.8
243.2
241.7
Weighted Avg. Shares Outstanding Diluted
248
248.7
248.3
Common Size
R&D to Revenue
29.4%
29.3%
28.4%
27.2%
26.1%
SG&A to Revenue
53.3%
53.4%
52.1%
50.7%
49.3%
48.4%
Stock-based Comp to Revenue
24%
23.5%
22.6%
21.9%
20.6%
20.5%
